P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL

P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL

Bibliographic Details
Main Authors:	F. Morschhauser, Y. Jiang, F. Jardin, A. F. Herrera, L. H. Sehn, C. Herbaux, C. Flowers, T. Phillips, A. López Guillermo, C. Diefenbach, G. P. Gregory, A. Kim, A. M. Barbui, S. Balasubramanian, W. Harris, J. Hirata, J. N. Paulson, C. Lee, G. Lenz
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847624.27308.c9

Similar Items

Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX
by: Michael Z. Liao, et al.
Published: (2023-12-01)

P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY
by: M. Trněný, et al.
Published: (2022-06-01)

P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL
by: Y. Song, et al.
Published: (2022-06-01)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
by: Weiping Li, et al.
Published: (2019-07-01)

Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
by: Mohammad Barouqa, et al.
Published: (2022-08-01)

Jews and felony in English communities and courts, 1190–1290*
by: Henry Summerson
Published: (2021-05-01)

P1280: TARGETED INHIBITION OF DHODH IS SYNERGISTIC WITH BCL2 BLOCKADE IN LYMPHOMA WITH CONCURRENT MYC AND BCL2 REARRANGEMENT
by: W. Mo, et al.
Published: (2022-06-01)

High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
by: Cheng-Chih Tsai, et al.
Published: (2021-03-01)

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
by: Walter Douglas Fairlie, et al.
Published: (2021-03-01)

The Massacres of the Jews under Richard I (A.D. 1189–1190)
by: Ted Booth
Published: (2021-09-01)

Two Treaties of Messina 1190–1191: Crusading Diplomacy of Richard I
by: Jan Malý
Published: (2017-06-01)

P1232: PRINCIPLES OF PRECISION ONCOLOGY IN PRIMARY REFRACTORY HIGH-GRADE B-CELL LYMPHOMA WITH MYC-, BCL2 AND/OR BCL6 REARRANGEMENTS (HGBL-DH/TH)
by: H. Witte, et al.
Published: (2022-06-01)

High-grade B-Cell lymphoma with MYC and BCL6 rearrangements associated with Richter transformation of chronic lymphocytic leukemia
by: Thomas S Rogers, et al.
Published: (2019-08-01)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
by: Julum Nwanze, et al.
Published: (2017-09-01)

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
by: Alison M. Moore, et al.
Published: (2018-05-01)

Makeshift 1190 (Pty) Ltd v Cilliers 2020 5 SA 538 (WCC)
by: EJ Marais
Published: (2021-01-01)

A1190-151: Design and prototype MOSFET/IGBT switches for efficient power converters
by: Nurhidayah, Siti
Published: (2016)

High‐grade B‐cell lymphoma with MYC and BCL2 rearrangements with abundant multinucleated giant tumor cells
by: Man Zhang, et al.
Published: (2023-05-01)

Redefining the high‐grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report
by: Socorro María Rodríguez‐Pinilla, et al.
Published: (2022-02-01)

Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
by: Vanja Zeremski, et al.
Published: (2023-07-01)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification
by: Masashi Miyaoka, et al.
Published: (2022-11-01)

Primary cutaneous diffuse large B‐cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
by: Yosuke Okada, et al.
Published: (2022-02-01)

The survival impact of combined expression of myc, bcl2 and bcl6 in diffuse large b cell lymphoma patients
by: Adelina BIRCEANU COROBEA, et al.
Published: (2018-06-01)

The Archaeology Of Gua Tupak From 1,190 B.P. To 170 B.P. In Bau, Sarawak
by: Gani, Nicholas
Published: (2010)

CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements
by: Delin Yuan, et al.
Published: (2021-03-01)

Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
by: R. K. Karakulov, et al.
Published: (2022-01-01)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
by: Yanjie Wang, et al.
Published: (2023-09-01)

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.
by: Steven Le Gouill, et al.
Published: (2023-08-01)

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
by: Jonathan Wawire, et al.
Published: (2019-04-01)

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements
by: Vito Olschewski, et al.
Published: (2021-02-01)

LA EDUCACIÓN DE EL DE ERUDITIONE FILIORUM NOBILIUM DE VICENTE DE BEAUVAIS (1190-1264)
by: Javier Vergara Ciordia
Published: (2012-01-01)

Un pouvoir d’abbé en acte(s) : Raoul d’Argences, abbé de Fécamp (1190-1219)
by: Fabien Paquet
Published: (2011-12-01)

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies
by: Schweighofer, C. D., et al.
Published: (2014)

No Evidence of Unexpected Transgenic Insertions in T1190 – A Transgenic Apple Used in Rapid Cycle Breeding – Following Whole Genome Sequencing
by: Andrea Patocchi, et al.
Published: (2021-08-01)

The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data
by: A E Misyurina, et al.
Published: (2019-07-01)

Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature
by: N G Gabeeva, et al.
Published: (2017-07-01)

Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning
by: Thomas E. Tavolara, et al.
Published: (2024-01-01)

Expression of Bcl-2 protein and the amplification of c-myc gene in patients with chronic myeloid leukemia
by: Strnad Milica, et al.
Published: (2006-01-01)

PB2161: CHARACTERISTICS OF AGGRESSIVE B-CELL LYMPHOMAS WITH MYC REARRANGEMENT
by: A. Ortuzar Pasalodos, et al.
Published: (2022-06-01)